Trials / Conditions / Recurrent Uveal Melanoma
Recurrent Uveal Melanoma
6 registered clinical trials studyying Recurrent Uveal Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma NCT02363283 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma NCT01979523 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma NCT01961115 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma NCT01835145 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye NCT01143402 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patient NCT01989572 | National Cancer Institute (NCI) | Phase 3 |